Peking University Pharmaceutical: the controlling shareholder intends to become the new Founder Group and Ping An of China will indirectly control the company

July 6,Peking University PharmaceuticalreleaseannouncementClaimed that it received the “About the Founder Group” from the manager of Peking University Founder Group Co., Ltd. (hereinafter referred to as “Founder Group”).<北大方正集团有限公司等五家公司重整计划>

Obtaining the Court’s Approval and Notification Letter of Reorganization Progress.” On the same day, the administrator received the (2020) Jing 01 Po No. 13-5 “Civil Ruling” delivered by Beijing No. 1 Intermediate People’s Court and ruled to approve the reorganization plan of five companies including Founder Group and terminate the reorganization procedure.

The announcement shows that as of the date of this announcement, Founder Group holds 85.60% of Peking University Medical’s shares. Peking University Medical holds approximately 70.328 million shares in the company, accounting for 11.80% of the company’s total shares. Peking University Medical holds Southwest Synthetic Pharmaceutical Group Co., Ltd. ( Hereinafter referred to as “Southwest Synthetic”) 100% equity, Southwest Synthetic holds approximately 170 million shares of the company, accounting for 28.58% of the company’s total shares.

According to the ruling of Beijing No. 1 Intermediate People’s Court and the effective reorganization plan, all the company’s equity directly held by Peking University Medical will be transferred to the proposed “New Founder Group” or its subordinate business platform.As a result, the company’s holdingshareholderIt is proposed to be changed to “New Founder Group”,Ping An of ChinaLifeInsuranceCo., Ltd. intends to become the controlling shareholder of “New Founder Group”,Ping An of ChinaInsurance(Group) Co., Ltd., as the controlling shareholder of Ping An Life, will indirectly controlPeking University Pharmaceutical。

　　Peking University PharmaceuticalSaid that since the “New Founder Group” has not yet been established, the timing of completing the change in the controlling shareholder’s shares is still uncertain. (Bi Jinling)

(Source: Financial Investment News)

Article source: Financial Investment News

Editor in charge: DF052

Original title: Peking University Pharmaceuticals: the controlling shareholder intends to become the new Founder Group and Ping An of China will indirectly control the company